- Trials with a EudraCT protocol (154)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
154 result(s) found for: Matrix.
Displaying page 1 of 8.
EudraCT Number: 2015-003674-32 | Sponsor Protocol Number: 1.1:12-6-2015 | Start Date*: 2016-02-23 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: The effect of Telmisartan on inflammatory processes in the vascular wall of abdominal aortic aneurysms. | ||
Medical condition: Abdominal aortic aneurysm with an indication for elective open surgical repair. | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003584-11 | Sponsor Protocol Number: MACT-IBK-2015 | Start Date*: 2015-12-11 | ||||||||||||||||
Sponsor Name:Medical University Innsbruck | ||||||||||||||||||
Full Title: Matrix-associated autologous chrondrocyte transplantation for grade four cartilage lesions of the knee joint - clinical and radiological outcome in correlation to the initial cell count of the cho... | ||||||||||||||||||
Medical condition: Cartilage lesion | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-004876-36 | Sponsor Protocol Number: 05/Q0108/5 | Start Date*: 2005-04-15 |
Sponsor Name:Addenbrookes Hospital NHS Trust | ||
Full Title: AN INVESTIGATION INTO THE ROLE OF MATRIX METALLOPROTEINASES (MMP’s) IN LOWER LIMB VASCULAR RESTENOSIS | ||
Medical condition: Post angioplasty and post vein graft stenosis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002365-34 | Sponsor Protocol Number: PM1434 | Start Date*: 2015-10-08 | |||||||||||
Sponsor Name:Polichem S.A. | |||||||||||||
Full Title: A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PARALLEL-GROUP TRIAL TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF P-3073 FOR TOPICAL TREATMENT OF NAIL PSORIASIS | |||||||||||||
Medical condition: Mild to moderate psoriatic fingernail/s | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) DE (Completed) CZ (Completed) PL (Completed) BG (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001265-92 | Sponsor Protocol Number: VAC065 | Start Date*: 2016-06-24 |
Sponsor Name:University of Oxford, CTRG | ||
Full Title: A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of adjuvanted R21 at different doses and the Combination Malaria Vaccine Candidate Regimen of adjuvanted R21 + ... | ||
Medical condition: Plasmodium falciparum infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019706-16 | Sponsor Protocol Number: PM0812 | Start Date*: 2010-07-27 | |||||||||||
Sponsor Name:POLICHEM | |||||||||||||
Full Title: A randomized, double blind, placebo controlled, parallel groups, pilot study to assess the effects of two new nail lacquers, cyclosporine 5% and calcipotriol 0.005%, in the treatment of nail psoriasis | |||||||||||||
Medical condition: Nail psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006727-39 | Sponsor Protocol Number: AGO/2006/012 | Start Date*: 2007-10-18 |
Sponsor Name:University Hospital Ghent | ||
Full Title: A prospective randomised controlled trial on the use of BMP-7 (Bone Morphogenetic Protein-7) (OP-1®) and demineralised bone matrix (DBM) in tibial non-union. | ||
Medical condition: non-union of the diaphysis of the tibia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011125-14 | Sponsor Protocol Number: RV4104A-2008-548 | Start Date*: 2009-07-06 | |||||||||||
Sponsor Name:Pierre Fabre Dermatologie | |||||||||||||
Full Title: A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solutio... | |||||||||||||
Medical condition: Patients suffering from distal-lateral or lateral subungual onychomycosis of one great toenail (the target nail) without matrix involvement | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002872-14 | Sponsor Protocol Number: VAC079 | Start Date*: 2019-11-12 | |||||||||||
Sponsor Name:University of Oxford / Clinical Trials and Research Governance | |||||||||||||
Full Title: A Phase I/IIa clinical trial to assess the safety, immunogenicity and efficacy of the blood-stage Plasmodium vivax malaria vaccine candidate PvDBPII in Matrix M1 in healthy adults living in the UK | |||||||||||||
Medical condition: Plasmodium vivax malaria | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001341-12 | Sponsor Protocol Number: UV/AP/21 | Start Date*: 2023-04-14 | |||||||||||
Sponsor Name:Red Andaluza de Diseño y Traslación en Terapias Avanzadas - Fundación Pública Andaluza Progreso y Salud M.P. | |||||||||||||
Full Title: Phase I-II, Multicenter, Randomized, Controlled, Proof of Concept Clinical Trial to determine feasibility, safety and efficacy of the use of Allogenic adipose-derived adult mesenchymal stem cells e... | |||||||||||||
Medical condition: Venous ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001066-15 | Sponsor Protocol Number: LR19912019 | Start Date*: 2019-08-16 | |||||||||||
Sponsor Name:Merete Hædersdal | |||||||||||||
Full Title: Treatment of hypertrophic scars using needle-free jet-injection of triamcinolone and 5-Fluorouracile: a prospective, controlled, randomized, single-blinded split-lesion trial. | |||||||||||||
Medical condition: Hypertrophic scars on 20 participants | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004637-16 | Sponsor Protocol Number: FJD-UHC-19-01 | Start Date*: 2020-11-13 |
Sponsor Name:FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE | ||
Full Title: Pilot, single-center, non-comparative clinical trial to assess the safety and preliminary efficacy of the administration of adipose tissue-derived MSCs (MSCs-TA) injected at the edges of the ulcer ... | ||
Medical condition: Lower limbs Chronic Wounds | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006611-68 | Sponsor Protocol Number: shey01.2006 | Start Date*: 2007-05-07 |
Sponsor Name:academic hospital Maastricht | ||
Full Title: Valsartan on top of standard therapy as a novel therapeutic strategy to treat cardiac dysfunction in patients with infammatory cardiomyopathies | ||
Medical condition: patients suffering from heartfailure and inflammatory cardiomyopthies | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000944-41 | Sponsor Protocol Number: FenS-FenD | Start Date*: 2015-04-20 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI" | |||||||||||||
Full Title: A PILOT STUDY TO TEST THE FEASIBILITY OF A TWO-ARM, DOUBLE BLIND, PARALLEL-GROUP, RANDOMIZED CONTROLLED TRIAL FOR THE COMPARISON OF THE DURATION OF THE ANALGESIC EFFICACY OF A SINGLE MATRIX TRANSDE... | |||||||||||||
Medical condition: Patients with oncological pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000413-48 | Sponsor Protocol Number: 8.1(IRE),2017.03.24 | Start Date*: 2015-07-01 |
Sponsor Name:ACS Biomarker | ||
Full Title: Bioprofiling response to mineralocorticoid receptor antagonists for the prevention of heart failure. A proof of concept clinical trial within the EU FP 7 “HOMAGE” programme « Heart OMics in AGing | ||
Medical condition: Elderly patients with Clinical and Biological risk factors for developing heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Prematurely Ended) NL (Prematurely Ended) GB (Prematurely Ended) DE (Completed) IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002115-96 | Sponsor Protocol Number: SCC215/P002900 | Start Date*: 2021-04-23 |
Sponsor Name:Klinikum Stuttgart, Landeshauptstadt Stuttgart gKAöR | ||
Full Title: Optimizing MATRix as remission induction in PCNSL: De-escalated induction treatment in newly diagnosed primary CNS lymphoma – a randomized phase III trial | ||
Medical condition: Primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system is a rare disorder confined to the cerebral parenchyma, leptomeninges, eyes or spinal cord. It accounts for 4 to 6% of al... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Trial now transitioned) AT (Trial now transitioned) IT (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001411-71 | Sponsor Protocol Number: R475-OA-1815 | Start Date*: 2018-12-03 | |||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | |||||||||||||
Full Title: Study to Evaluate Synovial Fluid in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip | |||||||||||||
Medical condition: Pain due to osteoarthritis of the knee | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002625-35 | Sponsor Protocol Number: PERIOC_CTP001 | Start Date*: 2015-01-26 |
Sponsor Name:PerioC Ltd | ||
Full Title: The effect of locally delivered ciclosporin as an adjunct to healing after treatment of periodontal pockets | ||
Medical condition: Moderate to severe chronic periodontitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000291-25 | Sponsor Protocol Number: 14I-BMT01 | Start Date*: 2014-09-10 |
Sponsor Name:IBSA Institut Biochimique S.A. | ||
Full Title: A single-center, prospective, randomized, double-blind, intra-patient (left-to-right) placebo-controlled, pilot study to assess the efficacy and safety of a betamethasone valerate 0.1% medicated pl... | ||
Medical condition: Nail Psoriasis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-000327-40 | Sponsor Protocol Number: 20110151 | Start Date*: 2013-05-27 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects with Heart Failure ... | |||||||||||||
Medical condition: Chronic Heart Failure and Left Ventricular Systolic Dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (Completed) LT (Completed) CZ (Completed) HU (Completed) IT (Completed) BG (Completed) DE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
